Advertisement

Topics

AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigmentosa

20:00 EDT 3 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigmentosa

NEXT ARTICLE

More From BioPortfolio on "AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigmentosa"

Quick Search
Advertisement